Video index

1. Call to order, logistical announcements, and roll call

2. Introduction of new Board Member: Mr. Jason LaFond (Term February 1, 2027)

3. Consideration of draft meeting minutes for December 11, 2025, meeting

4. Election of Vice Chair per TPI Bylaws and Motion adopted on December 11, 2025, regarding process

5. Discussion of the creation of TPI subcommittees related to continuing TPI implementation and submission of a revised business plan pursuant to TPI enabling statute, Texas Government Code, Chapter 2177 (enabling statute)

6. Operations and Finance Report

7. Presentation regarding status of Interagency Cooperation Contract(s) (ICC) between TPI (receiving agency) and the Texas A&M University System (College of Pharmacy) (performing agency) including

8. TPI staff updates and recommendations on the implementation of the TPI enabling statute including presentation, possible action and discussion of activity pursuant to and in development of the TPI Business Plan, including related work by and through contracted vendors and consideration of federal activities that may impact TPI’s statutory mission or functions, including but not limited to

9. TPI Advisory Council (TPIAC) members and other covered agency representatives have been invited to advise and engage in discussions with the TPI Board on matters and activities (see Texas Government Code, Section 2177.008, in general)

10. Discussion of external stakeholders input received by TPI Staff during the February 26, 2026, meeting held regarding the implementation of the TPI Business Plan

14. Review of action items from the current meeting and discussion of agenda items for future meetings and important dates

Mar 18, 2026 Texas Pharmaceutical Initiative Board

Full agenda
Share this video

1. Call to order, logistical announcements, and roll call

2. Introduction of new Board Member: Mr. Jason LaFond (Term February 1, 2027)

3. Consideration of draft meeting minutes for December 11, 2025, meeting

4. Election of Vice Chair per TPI Bylaws and Motion adopted on December 11, 2025, regarding process

5. Discussion of the creation of TPI subcommittees related to continuing TPI implementation and submission of a revised business plan pursuant to TPI enabling statute, Texas Government Code, Chapter 2177 (enabling statute)

6. Operations and Finance Report

7. Presentation regarding status of Interagency Cooperation Contract(s) (ICC) between TPI (receiving agency) and the Texas A&M University System (College of Pharmacy) (performing agency) including

8. TPI staff updates and recommendations on the implementation of the TPI enabling statute including presentation, possible action and discussion of activity pursuant to and in development of the TPI Business Plan, including related work by and through contracted vendors and consideration of federal activities that may impact TPI’s statutory mission or functions, including but not limited to

9. TPI Advisory Council (TPIAC) members and other covered agency representatives have been invited to advise and engage in discussions with the TPI Board on matters and activities (see Texas Government Code, Section 2177.008, in general)

10. Discussion of external stakeholders input received by TPI Staff during the February 26, 2026, meeting held regarding the implementation of the TPI Business Plan

14. Review of action items from the current meeting and discussion of agenda items for future meetings and important dates

© 2003-2026 Swagit Productions, LLC